Drug recall · November 27, 2013
Oxcarbazepine Oral Suspension recall
Why: Resuspension Problems: Recalled lot did not meet resuspendability requirements.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
- Lots / codes
Lot # 161304B, Exp. OCT 2013
- Quantity
- 10,267 bottles
- Company
- Boehringer Ingelheim Roxane Inc, Columbus, OH
- Distribution
- Nationwide
- Initiated
- April 3, 2013 · Voluntary: Firm initiated
- Classified
- November 20, 2013
- Reported
- November 27, 2013
- Ended
- February 11, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxcarbazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.